SCHEMBL29975520

SCHEMBL29975520

C[Sn](C)(C)c1cncc2cccc(Cl)c12

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NOS1 P29475 1/20 0.34
PARP1 P09874 1/20 0.33
AHR P35869 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2A6 P11509 1/20 0.32
TSHR P16473 2/20 0.31
LMNA P02545 1/20 0.31
GRIN1 Q05586 1/20 0.30
GRIN2A Q12879 1/20 0.30
ACHE P22303 1/20 0.30
KDM4E B2RXH2 1/20 0.30
MEN1 O00255 1/20 0.30
ALDH1A1 P00352 1/20 0.30
KMT2A Q03164 1/20 0.30
HSD17B10 Q99714 1/20 0.30
RXFP1 Q9HBX9 1/20 0.30
CYP11B2 P19099 1/20 0.30
BDKRB2 P30411 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22208149 1.00 NOS1 (0.34) NOS1PARP1AHRCYP1A2CYP2A6
SCHEMBL22208148 0.80 KDM4E (0.34) PARP1CYP1A2CYP2A6TSHRGRIN1
SCHEMBL30065085 0.80 KDM4E (0.34) PARP1CYP1A2CYP2A6TSHRGRIN1
SCHEMBL23043148 0.79 CYP1A2 (0.38) PARP1AHRCYP1A2CYP2A6TSHR
SCHEMBL29931540 0.79 CYP1A2 (0.38) PARP1AHRCYP1A2CYP2A6TSHR
SCHEMBL29230986 0.78 KCNH2 (0.33)
SCHEMBL23206118 0.76 PARP1 (0.39) NOS1PARP1AHRCYP1A2CYP2A6
SCHEMBL31552358 0.72 TNF (0.33)
SCHEMBL20974931 0.72 NOS1 (0.37) NOS1PARP1AHRCYP1A2CYP2A6
SCHEMBL24308562 0.72 NOS1 (0.37) NOS1PARP1AHRCYP1A2CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024083168-A1 OXAZEPINE COMPOUNDS COMPRISING A 6-AZA MOIETY AND USES THEREOF GENENTECH, INC. (US) 2024-04-25 WO disclosed
EP-4329757-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE Amgen Inc. (US) 2024-03-06 EP disclosed
EP-4087573-A1 KRAS G12C INHIBITORS Mirati Therapeutics, Inc. (US) 2022-11-16 EP disclosed
WO-2022232331-A1 HETEROCYCLIC COMPOUNDS AND METHODS OF USE AMGEN INC. (US) 2022-11-03 WO disclosed